Yakira Capital Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Yakira Capital Management’s Portfolio IQMDU Stock Details IQMDU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.02M	–	420
2022 Q4	$1.02M	Hold	100,000	–	–	0.21%	122
2022 Q3	$1.01M	Hold	100,000	–	–	0.15%	161
2022 Q2	$1M	Hold	100,000	–	–	0.16%	170
2022 Q1	$1.01M	Hold	100,000	–	–	0.14%	180
2021 Q4	$1.02M	Buy	+100,000	New	+$1.01M	0.13%	170

Other funds holding IQMDU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

BHWM

Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Yakira Capital Management's IQMDU Position: Q1 2023 in Review

Yakira Capital Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Yakira Capital Management first reported a position in IQMDU in Q4 2021 and held it in 5 quarters. The position peaked at $1.02M in Q4 2022. 6 funds tracked by Wall St. Rank hold IQMDU as of Q1 2023.

Yakira Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
Yakira Capital Management sold 100,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2023, an estimated $1.02M.
Yakira Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
Yakira Capital Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $1.02M in Q4 2022.
6 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2023.

Based on Yakira Capital Management's 13F filing for Q1 2023, filed 12 May 2023.